|
1
|
Gupta B, Parvizi S and Mohamed MD: Bietti
crystalline dystrophy and choroidal neovascularisation. Int
Ophthalmol. 31:59–61. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mansour AM, Uwaydat SH and Chan CC:
Long-term follow-up in Bietti crystalline dystrophy. Eur J
Ophthalmol. 17:680–682. 2007.PubMed/NCBI
|
|
3
|
Nakano M, Kelly EJ, Wiek C, Hanenberg H
and Rettie AE: CYP4V2 in Bietti's crystalline dystrophy: Ocular
localization, metabolism of ω-3-polyunsaturated fatty acids, and
functional deficit of the p.H331P variant. Mol Pharmacol.
82:679–686. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wada Y, Itabashi T, Sato H, Kawamura M,
Tada A and Tamai M: Screening for mutations in CYP4V2 gene in
Japanese patients with Bietti's crystalline corneoretinal
dystrophy. Am J Ophthalmol. 139:894–899. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mataftsi A, Zografos L, Millá E, Secrétan
M and Munier FL: Bietti's crystalline corneoretinal dystrophy: A
cross-sectional study. Retina. 24:416–426. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jurklies B, Jurklies C, Schimdt U and
Wessing A: Biettis crystalline dystrophy of the retina and cornea.
Retina. 19:168–171. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Welch R: Biettis tapetoretinal
degeneration with marginal corneal dystrophy: Crystalline
retinopathy. Trans Am Ophthalmol Soc. 75:164–179. 1977.PubMed/NCBI
|
|
8
|
Liu DN, Liu Y, Meng XH and Yin ZQ: The
characterization of functional disturbances in Chinese patients
with Bietti's crystalline dystrophy at different fundus stages.
Graefes Arch Clin Exp Ophthalmol. 250:191–200. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Saatci AO, Doruk HC and Yaman A: Cystoid
Macular Edema in Bietti's Crystalline Retinopathy. Case Rep
Ophthalmol Med. 2014:9648922014.PubMed/NCBI
|
|
10
|
Kojima H, Otani A, Ogino K, Nakagawa S,
Makiyama Y, Kurimoto M, Guo C and Yoshimura N: Outer retinal
circular structures in patients with Bietti crystalline
retinopathy. Br J Ophthalmol. 96:390–393. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Malik A, Sood S and Narang S: Successful
treatment of choroidal neovascular membrane in retinitis pigmentosa
with intravitreal bevacizumab. Int Ophthalmol. 30:42–58. 2010.
View Article : Google Scholar
|
|
12
|
Parodi M Battaglia, Iacono P and Bandello
F: Antivascular endothelial growth factor in hereditary
dystrophies. Dev Ophthalmol. 46:107–110. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bernauer W and Daicker B: Biettis
corneal–retinal dystrophy: A 16-year progression. Retina. 12:18–20.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Parodi M Battaglia, De Benedetto U,
Knutsson KA, Scotti F, Librando A, Bandello F and Iacono P:
Juxtafoveal choroidal neovascularization associated with retinitis
pigmentosa treated with intravitreal bevacizumab. J Ocul Pharmacol
Ther. 28:202–204. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Glaser BM, Campochiaro PA, Davis JL Jr and
Jerdan JA: Retinal pigment epithelial cells release inhibitors of
neovascularization. Ophthalmology. 94:780–784. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fong AM, Koh A, Lee K and Ang CL: Bietti's
crystalline dystrophy in Asians: Clinical, angiographic and
electrophysiological characteristics. Int Ophthalmol. 29:459–470.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Leveziel N, Caillaux V, Bastuji-Garin S,
Zmuda M and Souied EH: Angiographic and optical coherence
tomography characteristics of recent myopic choroidal
neovascularization. Am J Ophthalmol. 155:913–919. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Iu LP and Kwok AK: An update of treatment
options for neovascular age-related macular degeneration. Hong Kong
Med J. 13:460–470. 2007.PubMed/NCBI
|
|
19
|
Schouten JS, La Heij EC, Webers CA,
Lundqvist IJ and Hendrikse F: A systematic review on the effect of
bevacizumab in exudative age-related macular degeneration. Graefes
Arch Clin Exp Ophthalmol. 247:1–11. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ahn SJ, Woo SJ, Kim KE and Park KH:
Association between choroidal morphology and anti-vascular
endothelial growth factor treatment outcome in myopic choroidal
neovascularization. Invest Ophthalmol Vis Sci. 54:2115–2122. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Plafker SM, O'Mealey GB and Szweda LI:
Mechanisms for countering oxidative stress and damage in retinal
pigment epithelium. Int Rev Cell Mol Biol. 298:135–177. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang H, Barteselli G, Freeman WR, Lee SN,
Chhablani J, El-Emam S and Cheng L: Temporal pattern of
resolution/recurrence of choroidaln neovascularization during
bevacizumab therapy for wet age-related macular degeneration. Int J
Ophthalmol. 6:600–605. 2013.PubMed/NCBI
|
